文献速递乳腺癌放疗

部分乳腺照射试验的荟萃分析

A Meta-Analysis of Trials of Partial Breast Irradiation.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2022-09-22

该荟萃分析汇总15项随机试验、共16474例浸润性乳腺癌或导管原位癌患者,比较部分乳腺照射(PBI)与全乳照射(WBI)。PBI组同侧乳腺事件比例为5.0%,WBI组为2.8%(RR 1.72,95%CI 1.47-2.02);PBI的疗效与所采用的技术相关。

要点

  • PBI组同侧乳腺事件为5.0%,WBI组为2.8%(RR 1.72,95%CI 1.47-2.02)。
  • 未采用CT计划的外照射和术中放疗的RR分别为2.06和2.79,多导管近距离放疗和采用CT计划的外照射的RR分别为1.21和1.25。
  • 排除未采用CT计划的外照射和术中放疗试验后,同侧乳腺事件为3.3%对2.6%(RR 1.25,95%CI 1.00-1.55,P=0.05),未见异质性(P=0.92)。

核心结论

  • 总体而言,WBI比PBI更有效,但PBI的疗效与技术相关。
  • 当PBI采用未采用CT计划的外照射或术中放疗时,其疗效较差。
  • 采用多导管近距离放疗或采用CT计划的外照射的PBI在统计学上趋于不如WBI有效,但组间同侧乳腺事件的绝对差异很小(<1%),作者认为这支持考虑PBI的女性采用这些方法。

研究设计与样本

  • 对已发表的随机试验汇总数据进行荟萃分析,比较PBI与WBI在浸润性乳腺癌和导管原位癌患者中的有效性。
  • 共纳入15项试验、16474例患者;主要终点为任何同侧乳腺事件(浸润性或非浸润性),次要终点为急性和晚期毒性。
  • 采用固定效应模型和逆方差法汇总随机试验结果。

主要发现

  • 入组患者多数年龄>60岁、为T1N0分级1至2的病变并接受激素治疗。
  • PBI组同侧乳腺事件比例为5.0%,WBI组为2.8%(RR 1.72;95%CI 1.47-2.02)。
  • 4种PBI技术间存在异质性(P=0.0002):未采用CT计划的外照射RR 2.06(95%CI 1.36-3.12);近距离放疗RR 1.21(95%CI 0.65-2.25);术中放疗RR 2.79(95%CI 2.08-3.73);采用CT计划的外照射RR 1.25(95%CI 0.99-1.58)。
  • 排除未采用CT计划的外照射和术中放疗试验后,同侧乳腺事件分别为3.3%对2.6%(RR 1.25;95%CI 1.00-1.55;P=0.05),未见异质性(P=0.92)。
  • 总体上PBI的急性毒性较少,晚期毒性的影响因技术而异。

关键数值与推荐

  • PBI组同侧乳腺事件为5.0%,WBI组为2.8%(RR 1.72;95%CI 1.47-2.02)。
  • 未采用CT计划的外照射RR 2.06(95%CI 1.36-3.12);近距离放疗RR 1.21(95%CI 0.65-2.25);术中放疗RR 2.79(95%CI 2.08-3.73);采用CT计划的外照射RR 1.25(95%CI 0.99-1.58)。
  • 排除未采用CT计划的外照射和术中放疗试验后,同侧乳腺事件为3.3%对2.6%(RR 1.25;95%CI 1.00-1.55;P=0.05),未见异质性(P=0.92)。

临床怎么用

  • 作者认为,对于考虑PBI的女性,多导管近距离放疗或采用CT计划的外照射可作为支持选择,因为其与WBI的同侧乳腺事件绝对差异很小(<1%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Partial breast irradiation (PBI) is the delivery of radiation therapy (RT) limited to the tumor bed after breast conserving surgery. The results of recent trials of PBI compared with whole breast irradiation (WBI) have suggested conflicting results with respect to local control and toxicity. The purpose of this meta-analysis was to assess effectiveness of PBI and to compare the different techniques. METHODS AND MATERIALS: A meta-analysis of aggregate data from published randomized trials was performed to examine the effectiveness of PBI compared with WBI in patients with invasive breast cancer and ductal carcinoma in situ. Relevant data were extracted. The primary outcome was any ipsilateral breast event (invasive or noninvasive). Secondary outcomes included acute and late toxicity. The results of randomized trials were pooled using a fixed effects model and the inverse variance method. RESULTS: Fifteen trials involving 16,474 patients were identified. The majority of enrolled patients were >60 years of age and had T1N0 grade 1 to 2 disease treated with hormone therapy. The percent of ipsilateral breast events was higher in patients treated with PBI compared with WBI (5.0% vs 2.8%; risk ratio [RR], 1.72; 95% confidence interval [CI], 1.47-2.02). Heterogeneity (P = .0002) was observed between the 4 PBI techniques: external beam RT without computed tomography (CT) planning (RR, 2.06; 95% CI, 1.36-3.12); brachytherapy (RR, 1.21; 95% CI, 0.65-2.25); intraoperative RT (RR, 2.79; 95% CI, 2.08-3.73); and external beam RT with CT planning (RR, 1.25; 95% CI, 0.99-1.58). When external beam RT without CT planning and intraoperative RT trials were excluded, the percent of ipsilateral breast events was 3.3% versus 2.6%, respectively (RR, 1.25; 95% CI, 1.00-1.55; P = .05), and no heterogeneity was observed (P = .92). Overall, acute toxicity was less with PBI, and the effect on late toxicity varied by technique. CONCLUSIONS: Overall, WBI was more effective than PBI, but the effectiveness of PBI was technique related. PBI was less effective when given by external beam RT without CT planning or intraoperative therapy. Although PBI given by multicatheter brachytherapy or external beam RT with CT planning tended to be statistically less effective than WBI, the absolute difference between groups for ipsilateral breast events was very small (<1%), supporting these approaches for women considering PBI.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Goldberg M, Bridhikitti J, Khan AJ, et al. A Meta-Analysis of Trials of Partial Breast Irradiation. Int J Radiat Oncol Biol Phys. 2022. PMID: 36155214. doi:10.1016/j.ijrobp.2022.09.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。